Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.biocel.2019.105611 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567].
Genes Dis
November 2024
Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA.
[This corrects the article DOI: 10.1016/j.gendis.
View Article and Find Full Text PDFCorrigendum to "MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma" [Redox Biol. 68 (2023) 102956].
Redox Biol
February 2024
Department of Urology, Nanjing Drum Tower Hospital, Affliated Hospital of Medical School, Nanjing University, Institute of Urology Nanjing University, Nanjing, Jiangsu, 210008, China. Electronic address:
Corrigendum to "PRMT5-activated c-Myc promote bladder cancer proliferation and invasion through up-regulating NF-κB pathway" [Tissue Cell 76 (2022) 101788].
Tissue Cell
December 2023
Department of Emergency, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China. Electronic address:
Corrigendum: SNORA72 activates the Notch1/c-Myc pathway to promote stemness transformation of ovarian cancer cells.
Front Cell Dev Biol
August 2022
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
[This corrects the article DOI: 10.3389/fcell.2020.
View Article and Find Full Text PDFCorrigendum to 'TAZ is indispensable for c-MYC-induced hepatocarcinogenesis' [J Hepatol (2022) 123-134].
J Hepatol
March 2022
Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!